On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma
Hung‐Wei Wang(China Medical University), Cheng‐Yuan Peng(China Medical University), Jung‐Ta Kao(China Medical University), Wei‐Fan Hsu(China Medical University), Chun‐Che Lin(China Medical University), Hsueh‐Chou Lai(China Medical University), Po‐Heng Chuang(China Medical University), Guan‐Tarn Huang(National Taiwan University Hospital), Jaw‐Town Lin(E-Da Hospital), Wen‐Pang Su(China Medical University)
Cited by 16
Related Papers
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653
Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022
|Gastroenterology|2024|449
Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy
|Annals of Internal Medicine|2016|364